Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
Completed
1,214 enrolled
Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
Completed
192 enrolled
ROOT
Completed
167 enrolled
Impact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III Astrocytoma
Completed
811 enrolled
RIGEL
Completed
80 enrolled
Social Determinants of Health in Glioblastoma Population
Completed
100 enrolled
Biomarkers for Prognosis of Glioblastoma (GBM)
Completed
19 enrolled
Quality of Life and Patient Needs in Advanced High Grade Gliomas
Completed
55 enrolled
Immunophenotyping From Blood of Patients With Malignant Gliomas
Completed
50 enrolled
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
Completed
142 enrolled
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
Completed
112 enrolled
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Completed
55 enrolled
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Completed
76 enrolled
Natural History of Patients With Brain and Spinal Cord Tumors
Completed
3,050 enrolled
Study of Blood and Cheek Cell Samples From Patients With Glioma
Completed
1,709 enrolled
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Completed
631 enrolled
Radiomics
Completed
289 enrolled
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Completed
1,258 enrolled
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Completed
110 enrolled
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Completed
16 enrolled
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
Completed
1,804 enrolled
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Completed
135 enrolled
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Completed
180 enrolled
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
Completed
53 enrolled
Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
Completed
19 enrolled
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
Completed
82 enrolled
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
Completed
682 enrolled 10 charts
Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients
Completed
20 enrolled
Metabolic Syndrome in Childhood Cancer Survivors
Completed
512 enrolled
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Completed
359 enrolled
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
Completed
104 enrolled
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
Completed
25 enrolled
Nimotuzumab in Children With HGG
Completed
45 enrolled